These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33299868)

  • 1. The Application of
    Wang L; Chen K; Xu Q
    Biomed Res Int; 2020; 2020():3687134. PubMed ID: 33299868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for predicting high dose methotrexate associated acute kidney injury in children with acute lymphoblastic leukemia.
    Li H; Xu Q; Wang Y; Chen K; Li J
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):95-103. PubMed ID: 31676986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes is a risk factor for high-dose methotrexate-associated AKI in lymphoma patients.
    Wang Y; Wei L; Guan Y; Wang Q; Xie Q; Hao C
    Ren Fail; 2020 Nov; 42(1):1111-1117. PubMed ID: 33164656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study.
    Mikkelsen TS; Mamoudou AD; Tuckuviene R; Wehner PS; Schroeder H
    Pediatr Blood Cancer; 2014 Feb; 61(2):297-301. PubMed ID: 24039194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is hypoalbuminemia a risk factor for high-dose methotrexate toxicity in children with acute lymphoblastic leukemia?
    Barakat S; Assem H; Salama M; Mikhael N; El Chazli Y
    J Egypt Natl Canc Inst; 2022 Apr; 34(1):17. PubMed ID: 35434757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single assessment of methotrexate levels at 42 hours permits safe administration and early discharge in children with lymphoblastic lymphoma and leukemia receiving high-dose methotrexate.
    Totadri S; Srinivasan HN; Joseph LL; Boddu D; Mathew LG; John R
    Pediatr Hematol Oncol; 2021 Aug; 38(5):434-443. PubMed ID: 33764242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic renal scintigraphy with 99mTc-DTPA for the assessment of renal function after therapy of acute lymphoblastic leukemia in children.
    Listewnik MH; Peregud-Pogorzelski J; Birkenfeld B; Matacz M; Zorga P; Szychot E; Piwowarska-Bilska H; Brodkiewicz A
    Ann Acad Med Stetin; 2012; 58(1):49-54. PubMed ID: 23547395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating Intestinal Permeability by Measuring Plasma Endotoxin and Diamine Oxidase in Children with Acute Lymphoblastic Leukemia Treated with High-dose Methotrexate.
    Meng Y; Zhang Y; Liu M; Huang YK; Zhang J; Yao Q; Zhao YL; Xiong JJ
    Anticancer Agents Med Chem; 2016; 16(3):387-92. PubMed ID: 26265099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia.
    Svahn T; Mellgren K; Harila-Saari A; Åsberg A; Kanerva J; Jónsson Ó; Vaitkeviciene G; Stamm Mikkelssen T; Schmiegelow K; Heldrup J
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Parenteral Glutamine on Methotrexate-induced Oral Mucositis in Children with Acute Lymphoblastic Leukemia.
    Chang YH; Yu MS; Wu KH; Hsu MC; Chiou YH; Wu HP; Peng CT; Chao YH
    Nutr Cancer; 2017 Jul; 69(5):746-751. PubMed ID: 28569624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Risk Factors in High-Dose Methotrexate-Induced Acute Kidney Injury in Childhood Acute Lymphoblastic Leukemia.
    Cheng DH; Lu H; Liu TT; Zou XQ; Pang HM
    Chemotherapy; 2018 Apr; 63(2):101-107. PubMed ID: 29672292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does vitamin A prevent high-dose-methotrexate-induced D-xylose malabsorption in children with cancer?
    Dagdemir A; Yildirim H; Aliyazicioglu Y; Kanber Y; Albayrak D; Acar S
    Support Care Cancer; 2004 Apr; 12(4):263-7. PubMed ID: 14767751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a model to predict acute kidney injury following high-dose methotrexate in patients with lymphoma.
    Rice ML; Barreto EF; Rule AD; Martin CE; Truong HL; Mara KC; Kashani KB; Thompson CA; Witzig TE; Barreto JN
    Pharmacotherapy; 2024 Jan; 44(1):4-12. PubMed ID: 37926860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the glomerular filtration rate in patients with type 2 diabetes: An assessment of the agreement between
    Moralidis E; Papanastasiou E; Didangelos T; Hilidis I; Siountas A; Arsos G
    Diabetes Res Clin Pract; 2020 Mar; 161():108079. PubMed ID: 32057963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia.
    Kaya Z; Gursel T; Bakkaloglu SA; Kocak U; Atasever T; Oktar SO
    Pediatr Hematol Oncol; 2007 Jun; 24(4):257-67. PubMed ID: 17613868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for high-dose methotrexate associated acute kidney injury in patients with hematological malignancies.
    Amitai I; Rozovski U; El-Saleh R; Shimony S; Shepshelovich D; Rozen-Zvi B; Raanani P; Gafter-Gvili A; Gurion R
    Hematol Oncol; 2020 Oct; 38(4):584-588. PubMed ID: 32506594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of serum and urine fetuin-A levels in children with acute lymphoblastic leukemia during and after high-dose methotrexate therapy: Relation to toxicity.
    Ragab SM; Badr EA
    Hematology; 2016 Mar; 21(2):78-91. PubMed ID: 26268515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methotrexate administration and acute liver damage in children treated for acute lymphoblastic leukemia. A prospective study.
    Locasciulli A; Mura R; Fraschini D; Gornati G; Scovena E; Gervasoni A; Uderzo C; Masera G
    Haematologica; 1992; 77(1):49-53. PubMed ID: 1398282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective pediatric study comparing glomerular filtration rate estimates based on motion-robust dynamic contrast-enhanced magnetic resonance imaging and serum creatinine (eGFR) to
    Kurugol S; Afacan O; Lee RS; Seager CM; Ferguson MA; Stein DR; Nichols RC; Dugan M; Stemmer A; Warfield SK; Chow JS
    Pediatr Radiol; 2020 May; 50(5):698-705. PubMed ID: 31984436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities.
    Foster JH; Thompson PA; Bernhardt MB; Margolin JF; Hilsenbeck SG; Jo E; Marquez-Do DA; Scheurer ME; Schafer ES
    Cancer Chemother Pharmacol; 2019 Feb; 83(2):349-360. PubMed ID: 30488179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.